24
Participants
Start Date
July 31, 2014
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
Nizatidine
Nizatidine (150 mg) will be administered once daily for the first 3 days, then twice daily for days 4-9, and once on day 10.
Lisinopril
Lisinopril (10 mg) will be administered once daily for the first 3 days, then twice daily for days 4-9, and once on day 10.
Placebo
Placebo capsules to match active drug will be administered once daily for the first 3 days, then twice daily for days 4-9, and once on day 10.
Mayo Clinic in Rochester, Rochester
Mayo Clinic, Rochester
National Center for Research Resources (NCRR)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Adil Bharucha
OTHER